页面背景
导航背景
导航高亮
导航字体颜色
导航hover色
SPEAKERS
Nathalie Bastard
Fujirebio Europe

Dr. Nathalie Bastard, PhD started her career as a Neuroscientist in academic research, totaling 40+ peer-reviewed publications. She obtained a PhD in Biomedical Sciences at the University of Antwerp, Belgium, in 2011, for her work around the application of CSF biomarkers to aid in the differential diagnosis of dementia. She was supported by a PhD fellowship from the L’Oréal-UNESCO “For Women in Science” program and the Fund for Scientific Research (FWO), and was awarded the McKinsey and Company scientific prize. 

She joined Fujirebio Europe (formerly known as Innogenetics) in 2012 and currently holds the role of Strategic and Scientific Affairs Manager. Nathalie’s experience is crucial for guiding the development of clinical evidence for Fujirebio’s current biomarker portfolio and for evaluating evidence to expand existing indications for use. She also investigates new, innovative technologies and evaluates clinical utility and applicability for novel biomarkers in diagnostic areas of interest. She is responsible for developing the scientific publication strategy aimed to support product development, market access and regulatory submissions globally. She is an active and well-respected member of many local European and international consortia and projects (e.g. GBSC, AD-RIDDLE,…). 
Information

Shangri-La Hotel (by the Pearl River)

Guangzhou, China

November 9-10, Sat-Sun, 2024


Committee

World Dementia Council 

Alzheimer's Association

Guangzhou Mental Health Association

Affiliated Brain Hospital of Guangzhou Medical University


Conference Admin